NEURO-ONCOLOGY BOARD

The members of the Cognos Therapeutics, Inc. (Cognos) Neuro-Oncology Board are renowned medical experts in their fields. They have multidisciplinary expertise in translational research and affinity with pharma/drug/device development. Their affiliations are global and they have broad network associations in their respective medical communities.

The Cognos Neuro-Oncology Board is an advisory organ for the executive board of Cognos. The Neuro-Oncology Board provides advice from a clinical point of view about the design, context, and content of Cognos’ ongoing research and product development. In addition, the Neuro-Oncology Board advises Cognos on project proposals as they relate to internal and external funding efforts by the company. The Neuro-Oncology Board informs Cognos about relevant new clinical insights and developments.

Dr. Thomas Chen,

MD, PhD

CHAIRMAN

Dr. Mitchell Berger,

MD

BOARD MEMBER

Dr. Andrew Sloan,

MD

BOARD MEMBER

Dr. Marc Chamberlain,

MD

BOARD MEMBER

Dr. Hanni Gabra,

MD, PhD, FRCP

BOARD MEMBER

Dr. Frederick Lang Jr.,

MD, FACS, FAANS

BOARD MEMBER

Dr. Norman Litofsky,

MD

BOARD MEMBER

Dr. Manfred Westphal,

MD

BOARD MEMBER

Dr. Kevin O’Neill,

MD

BOARD MEMBER

Dr. John Sampson,

MD, Phd

BOARD MEMBER

Dr. Jeffrey Bruce,

MD, FACS

BOARD MEMBER

Dr. Russell Lonser,

MD

BOARD MEMBER